Related Experiment Video

Updated: Aug 14, 2026

On-Chip Endothelial Inflammatory Phenotyping
12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

Genetic risk factors for arterial thrombosis and inflammation

David Ginsburg1

  • 1Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, MI 48109-2216, USA. ginsburg@umich.edu

Hematology. American Society of Hematology. Education Program
|November 24, 2005
PubMed

Insights

Genetic factors influencing arterial thrombosis risk, a key cause of heart attack and stroke, are largely unknown. New genomic tools promise to uncover genetic insights into this critical area of cardiovascular disease.

Area of Science:

  • Cardiovascular Genetics
  • Thrombosis Pathophysiology
  • Molecular Medicine

Background:

  • Arterial thrombosis underlies myocardial infarction and stroke, major causes of mortality in developed nations.
  • Understanding genetic predispositions is crucial for preventing these conditions.
  • Current knowledge of genetic risk factors for arterial thrombosis lags behind that for venous thrombosis.

Purpose of the Study:

  • To review the current understanding of inherited genetic variations in hemostatic and inflammatory genes related to arterial thrombosis risk.
  • To highlight the knowledge gap in genetic factors contributing to arterial thrombosis.
  • To emphasize the potential of emerging genomic resources for future research.

Main Methods:

  • Literature review of existing research on genetic variations and arterial thrombosis.
  • Analysis of the current state of knowledge regarding hemostatic and inflammatory gene polymorphisms.
  • Discussion of the implications of new genomic technologies.

Main Results:

  • Significant progress has been made in identifying genetic risk factors for venous thrombosis.
  • Genetic factors contributing to arterial thrombosis risk remain largely unidentified.
  • Inherited variations in hemostatic and inflammatory genes are implicated but not fully understood in arterial thrombosis.

Conclusions:

  • The genetic basis of arterial thrombosis is not well-defined.
  • Advancements in genomic resources are expected to significantly enhance the study of arterial thrombosis pathophysiology.
  • Future research utilizing these tools will likely yield novel insights into the molecular mechanisms of arterial thrombosis and ischemic heart disease.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Inflammation01:38

Inflammation

Overview